Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Welch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Veterinary Record|July 26, 2002
RCVS fees for 2003A G Welch
Lancet (London, England)|August 5, 1995
Hepatitis C infection from anti-D immunoglobulinP R Foster, R V McIntosh, A G Welch
Lancet (London, England)|November 19, 1983
Non-A, non-B hepatitis from intravenous immunoglobulinA G Welch, B Cuthbertson, R V McIntosh, et al.
British Medical Journal (Clinical Research Ed.)|October 24, 1987
Aluminium and human albumin solutionsB Cuthbertson, W E McBay, A G Welch, et al.
Transfusion Medicine (Oxford, England)|March 1, 1997
Immunoglobulin for intravenous useP R Foster, A G Welch, B Cuthbertson, et al.
Transfusion Science|April 20, 2000
Removal of abnormal prion protein by plasma fractionationP R Foster, C McLean, A G Welch, et al.
Vox Sanguinis|April 15, 2000
Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma productsP R Foster, A G Welch, C McLean, et al.
Vox Sanguinis|August 31, 2002
Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulinH E Reichl, P R Foster, A G Welch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Veterinary Record|July 26, 2002
RCVS fees for 2003A G Welch
Lancet (London, England)|August 5, 1995
Hepatitis C infection from anti-D immunoglobulinP R Foster, R V McIntosh, A G Welch
Lancet (London, England)|November 19, 1983
Non-A, non-B hepatitis from intravenous immunoglobulinA G Welch, B Cuthbertson, R V McIntosh, et al.
British Medical Journal (Clinical Research Ed.)|October 24, 1987
Aluminium and human albumin solutionsB Cuthbertson, W E McBay, A G Welch, et al.
Transfusion Medicine (Oxford, England)|March 1, 1997
Immunoglobulin for intravenous useP R Foster, A G Welch, B Cuthbertson, et al.
Transfusion Science|April 20, 2000
Removal of abnormal prion protein by plasma fractionationP R Foster, C McLean, A G Welch, et al.
Vox Sanguinis|April 15, 2000
Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma productsP R Foster, A G Welch, C McLean, et al.
Vox Sanguinis|August 31, 2002
Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulinH E Reichl, P R Foster, A G Welch, et al.
Pageof 1